Insider Selling: Andrew Krakauer Unloads 30,761 Shares of Cantel Medical Corp. Stock (CMN)
Cantel Medical Corp. (NYSE:CMN) CEO Andrew Krakauer unloaded 30,761 shares of Cantel Medical Corp. stock on the open market in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $31.72, for a total value of $975,738.92. Following the transaction, the chief executive officer now directly owns 227,781 shares in the company, valued at approximately $7,225,213. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
Cantel Medical Corp. (NYSE:CMN) traded down 0.89% on Monday, hitting $32.2499. 64,232 shares of the company’s stock traded hands. Cantel Medical Corp. has a 52-week low of $16.1133 and a 52-week high of $32.72. The stock’s 50-day moving average is $27.9 and its 200-day moving average is $24.09. The company has a market cap of $1.307 billion and a P/E ratio of 34.25.
Cantel Medical Corp. (NYSE:CMN) last released its earnings data on Thursday, September 26th. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.02. The company had revenue of $113.97 million for the quarter, compared to the consensus estimate of $105.75 million. During the same quarter last year, the company posted $0.31 earnings per share. Cantel Medical Corp.’s revenue was up 15.4% compared to the same quarter last year. Analysts expect that Cantel Medical Corp. will post $1.03 EPS for the current fiscal year.
Cantel Medical Corp (NYSE:CMN) is a provider of infection prevention and control products and services in the healthcare market.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.